查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路
市场调查报告书
商品编码
1567797

2030 年亚太地区痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路

Asia Pacific Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 订单完成后即时交付

价格

2022年亚太地区痤疮药物市场价值为1,508.26美元，预计到2030年将达到2,672.90百万美元；预计 2023 年至 2030 年复合年增长率为 7.4%。

新药上市推动亚太青春痘药物市场

创新药物的发展，包括局部和全身药物，从根本上改变了痤疮的治疗方法。 2024 年，澳洲治疗产品管理局 (TGA) 批准印度 Sun Pharmaceutical 的 Winlevi（clascoterone）乳膏 1% 用于治疗 12 岁及以上个体的寻常痤疮。 2022 年，Sun Pharmaceutical Industries 扩大了与 Cassiopea 在痤疮治疗方面的合作范围。它已签署了 WINLEVI（clascoterone）乳膏 1% 的许可和供应合约的延期协议，将地理范围扩大到包括澳洲、纽西兰、日本、巴西、墨西哥和俄罗斯。 2023 年，Torii Pharmaceutical Co., Ltd. 和 Nogra Pharma（一家临床阶段生物技术公司，为免疫发炎介导的疾病创造新型疗法）宣布达成 NAC-GED-0507 的开发和商业化的外包许可协议日本治疗寻常痤疮。

新药上市还包括具有改进功效、增强安全性和减少副作用的先进配方，满足寻求有效痤疮管理的个人不断变化的需求。根据Bausch Health Companies Inc. 及其皮肤科业务Ortho Dermatologics 于2023 年10 月发布的声明，美国食品药物管理局(FDA) 批准了由1.2%、0.15% 和3.1 成分组成的CABTREO 外用凝胶的新药申请分别为%克林霉素磷酸盐、阿达帕林和过氧化苯甲酰。这是一种针对 12 岁或以上患者寻常性痤疮的局部治疗方法。 CABTREO 是 FDA 批准的第一个也是唯一一个局部三重痤疮治疗药物，以固定剂量形式提供。该公司的目标是在 2024 年第一季向患者提供这种凝胶。

类维生素A、抗雄激素和免疫调节剂等新型药物的引入，进一步扩大了医疗保健专业人员和痤疮患者的治疗选择。新药的持续推出刺激了竞争，促进了创新，并鼓励了皮肤科製药业的研发投资。对治疗痤疮的个人化和有针对性的治疗方法的高度关注为新药的出现奠定了基础，以改善患者的治疗结果和满意度。因此，新药的推出极大地促进了亚太地区痤疮药物市场的进步。

亚太地区痤疮药物市场概况

亚太地区痤疮药物市场分为中国、日本、印度、澳洲和韩国。预计该地区在预测期内将创下最快的复合年增长率。该地区痤疮药物市场的预期成长归因于主要参与者对扩大其在发展中地区的业务的兴趣日益浓厚以及护肤行业的繁荣。中国不断增长的可支配收入增加了消费者在护肤品上的支出，从而促进了痤疮药物市场规模的扩大。痤疮盛行率的增加可能与生活方式的改变和环境因素有关，这进一步刺激了对有效治疗的需求。随着中国消费者将护肤放在首位，製药公司正在推出创新配方来满足这一不断增长的需求。因此，先进技术、经济因素和不断变化的医疗保健重点共同引导中国痤疮药物市场实现前所未有的成长。

亚太地区痤疮药物市场收入及 2030 年预测（百万美元）

亚太地区痤疮药物市场细分

亚太地区痤疮药物市场根据治疗类别、配方、类型、痤疮类型、配销通路和国家进行细分。

根据治疗类别，亚太地区痤疮药物市场分为类维生素A、过氧化苯甲酰、抗生素、水杨酸等。 2022 年，类视黄醇细分市场占据最大份额。

从剂型来看，亚太地区痤疮药物市场分为外用药物和口服药物。 2022 年，外用药物领域占据更大的份额。

按类型划分，亚太地区痤疮药物市场分为处方药和非处方药。 2022 年，处方药领域占据更大的最大份额。

根据痤疮类型，亚太地区痤疮药物市场分为非发炎性痤疮和发炎性痤疮。 2022 年，发炎性痤疮部分占据了更大的份额。

就配销通路而言，亚太痤疮药物市场分为药房和药局、零售店和电子商务。 2022 年，药局和药局细分市场占据最大份额。

按国家/地区划分，亚太地区痤疮药物市场分为澳洲、中国、印度、日本、韩国和亚太地区其他地区。 2022年，中国主导亚太地区痤疮药物市场。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Mayne Pharma Group Ltd、Almirall SA、Johnson & Johnson、Bausch Health Companies Inc、Galderma SA、Pfizer Inc、GSK Plc 和 Viatris Inc 是亚太地区运营的一些领先公司痤疮药物市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区痤疮药物市场格局

  • PEST分析
  • 外用和口服药物的定价分析
  • 接受痤疮治疗的患者群

第 5 章：亚太地区痤疮药物市场 - 主要市场动态

  • 亚太地区痤疮药物市场 - 主要市场动态
  • 主要市场驱动因素
    • 严重痤疮的盛行率不断增加
    • 新药上市
  • 主要市场限制
    • 与痤疮药物相关的副作用
  • 主要市场机会
    • 基于尖端技术和数据驱动策略的个人化治疗方案
  • 未来趋势
    • 对有机和自然疗法的需求激增
  • 驱动因素和限制的影响：

第 6 章：痤疮药物市场 - 亚太地区市场分析

第 7 章：亚太地区痤疮药物市场分析 - 按治疗类别

  • 类维生素A
  • 过氧化苯甲酰
  • 抗生素
  • 水杨酸
  • 其他的

第 8 章：亚太地区痤疮药物市场分析 - 按配方

  • 外用药物
  • 口服药物

第 9 章：亚太地区痤疮药物市场分析 - 按类型

  • 处方药
  • 非处方药

第 10 章：亚太地区痤疮药物市场分析 - 按痤疮类型

  • 非发炎性痤疮
  • 发炎性痤疮

第 11 章：亚太地区痤疮药物市场分析 - 按配销通路

  • 药局和药局
  • 零售店
  • 电子商务

第 12 章：亚太地区痤疮药物市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 13 章：痤疮药物市场-产业格局

  • 概述
  • 痤疮药物市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述
  • Farmapiel 提供的产品与其他公司痤疮产品的比较

第 14 章：公司简介

  • Teva Pharmaceutical Industries Ltd
  • Mayne Pharma Group Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc

第 15 章：附录

Product Code: BMIRE00030658

The Asia Pacific acne medication market was valued at US$ 1,508.26 in 2022 and is expected to reach US$ 2,672.90 million by 2030; it is estimated to register at a CAGR of 7.4% from 2023 to 2030.

Launch of Novel Drugs Boosts Asia Pacific Acne Medication Market

Innovative pharmaceutical developments, including topical and systemic medications, have fundamentally reshaped treatment approaches for acne. In 2024, the Australian Therapeutic Goods Administration (TGA) approved Winlevi (clascoterone) cream 1% from Sun Pharmaceutical of India to treat acne vulgaris in individuals 12 years of age and older. In 2022, Sun Pharmaceutical Industries broadened the scope of its collaboration with Cassiopea with respect to an acne treatment. It has signed extension agreements to the license and supply contracts for WINLEVI (clascoterone) cream 1 percent, enlarging the geographical scope to encompass Australia, New Zealand, Japan, Brazil, Mexico, and Russia. In 2023, Torii Pharmaceutical Co., Ltd. and Nogra Pharma, a clinical-stage biotechnology company creating novel therapeutics for immune-inflammatory-mediated diseases, announced an out-licensing agreement for the development and commercialization of NAC-GED-0507 for the treatment of acne vulgaris in Japan.

Novel drug launches also include advanced formulations with improved efficacy, enhanced safety profiles, and reduced side effects, catering to the evolving needs of individuals seeking effective acne management. According to a statement released in October 2023 by Bausch Health Companies Inc. and its dermatology business-Ortho Dermatologics-the US Food and Drug Administration (FDA) approved the New Drug Application for CABTREO topical gel composed of 1.2%, 0.15%, and 3.1% clindamycin phosphate, adapalene, and benzoyl peroxide, respectively. This is a topical treatment indicated for acne vulgaris in patients aged 12 or older. CABTREO is the first and only topical triple combination acne therapy approved by the FDA, which is offered in a fixed-dose form. The company aims to make this gel available for patients in Q1 2024.

The introduction of novel medications, such as retinoids, anti-androgens, and immune modulators, has further expanded the therapeutic options available for healthcare professionals and individuals dealing with acne. The continuous introduction of new drugs stimulates competition, fosters innovation, and encourages research and development investments within the dermatological pharmaceutical industry. The heightened focus on personalized and targeted treatment approaches for treating acne forms a foundation for the advent of novel drugs to improve patient outcomes and satisfaction. Thus, the launch of novel drugs significantly contributes to the progress of the Asia Pacific acne medication market.

Asia Pacific Acne Medication Market Overview

The Asia Pacific acne medication market is segmented into China, Japan, India, Australia, and South Korea. This region is expected to record the fastest CAGR during the forecast period. The projected acne medication market growth in the region is ascribed to the burgeoning interest of major players in expanding their presence in developing regions and the flourishment of the skincare industry. China's nation's rising disposable income has heightened consumer spending on skincare, contributing to the expansion of the acne medication market size. The increased prevalence of acne, possibly linked to lifestyle changes and environmental factors, has further fueled demand for effective treatments. As Chinese consumers prioritize skincare for their well-being, pharmaceutical companies are introducing innovative formulations to meet this burgeoning demand. Thus, advanced technologies, economic factors, and evolving healthcare priorities are together steering the acne medication market toward unprecedented growth in China.

Asia Pacific Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Acne Medication Market Segmentation

The Asia Pacific acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Asia Pacific acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Asia Pacific acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Asia Pacific acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Asia Pacific acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Asia Pacific acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Asia Pacific acne medication market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Mayne Pharma Group Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the Asia Pacific acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. Asia Pacific Acne Medication Market - Key Market Dynamics

  • 5.1 Asia Pacific Acne Medication Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Increasing Prevalence of Severe Acne
    • 5.2.2 Launch of Novel Drugs
  • 5.3 Key Market Restraints
    • 5.3.1 Side Effects Associated with Acne Medication
  • 5.4 Key Market Opportunities
    • 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.5 Future Trends
    • 5.5.1 Upsurge in Need for Organic and Natural Treatments
  • 5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Asia Pacific Market Analysis

7. Asia Pacific Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Asia Pacific Acne Medication Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 China
      • 12.1.1.3 China: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 China: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 China: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 China: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 China: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 China: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Japan
      • 12.1.1.5 Japan: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Japan: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Japan: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Japan: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Japan: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Japan: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 India
      • 12.1.1.7 India: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 India: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 India: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 India: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 India: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 India: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.8 Australia
      • 12.1.1.9 Australia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.9.1 Australia: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.9.2 Australia: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.9.3 Australia: Acne Medication Market Breakdown, by Type
        • 12.1.1.9.4 Australia: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.9.5 Australia: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.10 South Korea
      • 12.1.1.11 South Korea: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.11.1 South Korea: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.11.2 South Korea: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.11.3 South Korea: Acne Medication Market Breakdown, by Type
        • 12.1.1.11.4 South Korea: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.11.5 South Korea: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.12 Rest of Asia Pacific
      • 12.1.1.13 Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.13.1 Rest of Asia Pacific: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.13.2 Rest of Asia Pacific: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.13.3 Rest of Asia Pacific: Acne Medication Market Breakdown, by Type
        • 12.1.1.13.4 Rest of Asia Pacific: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.13.5 Rest of Asia Pacific: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Mayne Pharma Group Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Almirall SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Johnson & Johnson
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Sun Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Bausch Health Companies Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 27. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 28. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 30. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 31. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 32. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 33. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 35. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 36. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 37. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 38. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 39. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 40. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 41. Recent Organic Growth Strategies in Acne Medication Market
  • Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. Asia Pacific Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Acne Medication Market Revenue (US$ Million), 2022-2030
  • Figure 5. Asia Pacific Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 6. Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 12. Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 15. Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Asia Pacific Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 18. Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Asia Pacific: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 25. Asia Pacific: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 26. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Growth Strategies in Acne Medication Market